Get started
Author

Éderson Mattos

Observed names: E. R. Mattos, E.R. Mattos, Ederson Mattos, Ederson R. Mattos, Ederson Roberto DE MATTOS, Ederson Roberto Mattos, Ederson Roberto de Mattos, Éderson Mattos, Éderson Roberto de Mattos, Mattos, Ederson, Éderson R. de Mattos, Éderson Roberto Mattos
Observed institution: Hospital Amaral Carvalho
ORCID: 0000-0003-2538-4082
Observed ORCID: 0000-0003-2538-4082
OpenAlex ID: A5002618806
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial
2025 · Lorenzo Falchi, Marcel Nijland, et al. · The Lancet · 50
BRUIN CLL-313: Randomized Phase III Trial of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
2025 · Wojciech Jurczak, Michal Kwiatek, et al. · Journal of Clinical Oncology · 25
PDF
Acute myeloid leukemia: update in diagnosis and treatment in Brazil
2011 · Ricardo Helman, Fabio Pires de Souza Santos, et al. · Einstein (São Paulo) · 11
PDF
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. I: Structuring centers for the multidisciplinary clinical administration and management of CAR-T cell therapy patients
2021 · Diego V. Clé, Alexandre V. Hirayama, et al. · Hematology Transfusion and Cell Therapy · 9
PDF
Chemiluminescent determination of leukocyte alkaline phosphatase: an advantageous alternative to the cytochemical assay
2007 · Marília P.P. Kanegae, Valdecir F. Ximenes, et al. · Journal of Clinical Laboratory Analysis · 9
Resuscitation fluid practices in Brazilian intensive care units: a secondary analysis of Fluid-TRIPS
2021 · Flavio Geraldo Rezende de Freitas, Naomi Hammond, et al. · Revista Brasileira de Terapia Intensiva · 7
Safety and Efficacy of Venetoclax, Cytarabine and Metformin for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia
2024 · Marcelo Pitombeira de Lacerda, Elenaide Nunes, et al. · Blood · 4
Brazilian Real-Life Experience of Multiple Myeloma (MMyBRAve): Improvement in Outcomes, But Remaining Diagnostic and Therapeutic Gaps
2024 · Vania Hungria, Rosane Isabel Bittencourt, et al. · Clinical Lymphoma Myeloma & Leukemia · 4
PDF
Disparities in Clinical Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia Treated in Public Versus Private Services in Brazil: Analysis of the Brazilian Acute Myeloid Leukemia Registry
2024 · Luiza Perruso, Abel Costa Neto, et al. · Blood · 3
PDF
A Brazilian Real-Life Experience of Multiple Myeloma Patients: Final Results from the Mmybrave Multi-Center Study
2022 · Vania T.M. Hungria, Rosane Bittencourt, et al. · Blood · 3
Lung cancer histology in a Brazil: A retrospective study of 1,887 patients.
2011 · G. Ismael, A. L. Coradazzi, et al. · Journal of Clinical Oncology · 3
Disseminated Intravascular Coagulation and Concomitant Central Nervous System Bleeding in Acute Monoblastic Leukemia: Case Report
2020 · B.B.L. Alvarenga, E. Manzo, et al. · Hematology Transfusion and Cell Therapy · 2
Clinical Features and Outcome of 148 Patients with Acute Promyelocytic Leukemia in Brazil.
2006 · Rafael H. Jácomo, Raul Melo, et al. · Blood · 2
Clinical validation of a 10-color flow cytometry panel to detect measurable residual disease in acute myeloid leukemia
2024 · Maura R.V. Ikoma-Colturato, Alef Rafael Severino, et al. · Leukemia Research · 1
Cd30 Negative/cd4 Positive Cytotoxic T Cell Lymphoma: a Rare Cutaneous Lymphoproliferative Disorder
2023 · Lais Pereira, Luiz Gustavo Rodrigues Barbosa, et al. · Hematology Transfusion and Cell Therapy · 1
P-117: Multiple Myeloma treatment patterns and outcomes in the public and private healthcare systems in Brazil: one country, two worlds
2021 · Vania Hungria, Rosane Bittencourt, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Sarcoma Histiocítico: Relato De Caso
2020 · L.P. Queiroz, C.F. Mascarenhas, et al. · Hematology Transfusion and Cell Therapy · 1
PDF
Determinantes De Não Receber Tratamento Específico Para Leucemia Mieloide Aguda No Brasil: Análise Do Registro Brasileiro De Lma
2026 · Luiza Luiza LAPOLLA PERRUSO, Abel COSTA, et al. · Hematology Transfusion and Cell Therapy
Apresentação Incomum Da Tricoleucemia Variante Com Progressão Extra Medular: Relato De Caso
2026 · Monica PIACENTINI LUIZON, Camila Pires DE OLIVEIRA, et al. · Hematology Transfusion and Cell Therapy
Real‐world outcomes of daratumumab, bortezomib, thalidomide and dexamethasone (Dara‐VTd) induction and lenalidomide maintenance in transplant‐eligible multiple myeloma
2026 · Edvan Q. Crusoé, Glaciano Ribeiro, et al. · British Journal of Haematology
PDF
Social determinants outweigh geographic barriers in Acute Myeloid Leukemia survival: Insights from a brazilian multicenter study
2025 · Luiza Perruso, Abel Costa, et al. · Blood
Daratumumab, Bortezomib, Thalidomide and Dexamethasone Followed by Lenalidomide Maintenance in Transplant-Eligible Multiple Myeloma Patients: Overall Survival Comparison with the CASSIOPEIA Trial
2025 · Edvan Crusoe, Glaciano Ribeiro, et al. · Clinical Lymphoma Myeloma & Leukemia
P-327 Real-World Data on the Daratumumab Plus Bortezomib, Thalidomide and Dexamethasone Followed by Lenalidomide Maintenance for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients
2024 · Edvan de Queiroz Crusoe, Glaciano Ribeiro, et al. · Clinical Lymphoma Myeloma & Leukemia
EE53 Cost-Minimization and Budget Impact Analysis of Venetoclax Versus Acalabrutinib for 1L and R/R Chronic Lymphocytic Leukemia in the Brazilian Public Healthcare System
2023 · E.R. Mattos, W. Follador, et al. · Value in Health
PDF
P-130: Brazilian ineligible multiple myeloma patients: real world data from a prospective multicenter platform
2022 · Edvan Crusoe, Glaciano Ribeiro, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 32
Citation count: 136
H-index: 6
I10-index: 3
Year
Topic
Type